America as we know it was built largely upon and because of our rail industry, and today it remains…
So-Called "Railway Safety Act" Constitutes a Political Handout to Big Labor That Does Nothing to Improve Safety At All
America as we know it was built largely upon and because of our rail industry, and today it remains a pillar of our economy.
Unfortunately, a destructive proposal before Congress misleadingly named the "Railway Safety Act" (RSA), part of broader surface transportation reauthorization, threatens great harm to our railroads.
Simply put, the bill has nothing to do with improving safety, but has a lot to do with advancing the political agenda of Big Labor. At a moment when inflation burdens American families and fragile supply chains remain vulnerable to disruption, the last thing our economy or rail sector need is another costly federal mandate imposed upon one of the nation’s most important transportation sectors.
As an initial matter, as noted by The Wall Street Journal, the…[more]
Sally Pipes, Founder, CEO and President of the Pacific Research Institute, discusses the biggest healthcare takeaways from a numbers perspective in the recently enacted “Big Beautiful Bill,” how cheap drugs from Canada can’t make America healthy, and the real culprit impeding drug competition.
Jeremy Nighohossian, Senior Fellow and Economist at the Competitive Enterprise Institute, discusses positive developments in healthcare, including changes in drug development, what the resignation of FDA Commissioner Marty Makary may mean for healthcare policy, and why Certificate of Need (CON) laws impede free market competition and access to care.
Sally Pipes, President and CEO of the Pacific Research Institute, discusses how America’s healthcare system has never been better at keeping patients alive and living longer, types of governmental activities and proposals that disrupt America’s cycle of innovation, and the real drivers of high drug costs in America.
Thomas Aiello, Senior Director of Government Affairs at the National Taxpayers Union, discusses the uphill battle President Trump’s “Big Beautiful Bill” is facing on Capitol Hill, the looming July 4th deadline, and how the battle in the Senate may ultimately result in improvements to the House version of the bill.
Phil Kerpen, President of American Commitment and Principal at the Committee to Unleash Prosperity, discuses the potential victories and disappointments in the current version of President Trump’s “big, beautiful bill,” the players to watch as the bill makes its way through the Senate, the recent analysis from the Congressional Budget Office (CBO), and other administration efforts underway to decrease the deficit and enhance growth.
William J. Conti, an attorney from Washington, DC, discusses the size and complexity of the “Big Beautiful Bill” that addresses tax policy, energy policy and immigration, and the economic potential impact of passing the REINS Act.
Sally Pipes, President and CEO of Pacific Research Institute, discusses her recently released book, “The World’s Medicine Chest: How America Achieved Pharmaceutical Supremacy and How to Keep It,” the horrible impacts of price controls, how single-payer healthcare systems fail children and cancer patients, and more.